Clinical Trials Directory

Trials / Conditions / Unresectable Dedifferentiated Liposarcoma

Unresectable Dedifferentiated Liposarcoma

6 registered clinical trials studyying Unresectable Dedifferentiated Liposarcoma — 3 currently recruiting.

StatusTrialSponsorPhase
RecruitingA Study of Mirdametinib in Combination With Palbociclib in People With Liposarcoma
NCT06843967
Memorial Sloan Kettering Cancer CenterPhase 1 / Phase 2
RecruitingMeasuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Po
NCT06422806
National Cancer Institute (NCI)Phase 3
RecruitingTesting Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposert
NCT05711615
National Cancer Institute (NCI)Phase 1
Active Not RecruitingTesting the Addition of Cemiplimab to Palbociclib for the Treatment of Advanced Dedifferentiated Liposarcoma
NCT05694871
Alliance for Clinical Trials in OncologyPhase 2
Active Not RecruitingA Study of Etrumadenant and Zimberelimab in People With Dedifferentiated Liposarcoma
NCT05886634
Memorial Sloan Kettering Cancer CenterPhase 2
CompletedNivolumab With or Without Ipilimumab in Treating Patients With Metastatic Sarcoma That Cannot Be Removed by Su
NCT02500797
National Cancer Institute (NCI)Phase 2